Vai al contenuto principale della pagina

Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019 Visualizza cluster
Pubblicazione: Washington : , : U.S. Government Publishing Office, , 2020
Descrizione fisica: 1 online resource (v, 97 pages) : illustrations
Soggetto topico: Insulin - Cost control
Prescription pricing - Government policy - United States
Pharmaceutical industry - United States
Drugs - United States - Cost control
Drugs - Prices - Government policy - United States
Soggetto genere / forma: Legislative hearings.
Note generali: "Serial No. 116-21."
Nota di bibliografia: Includes bibliographical references.
Altri titoli varianti: Priced out of a Lifesaving Drug
Titolo autorizzato: Priced out of a lifesaving drug  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910717377703321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui